Ageing commentary in Lancet Healthy Longevity

A commentary by Lynne Cox et al. on ageing, geroprotectors and COVID published in the Lancet Healthy Longevity:

Tackling immunosenescence to improve COVID-19 outcomes and vaccine response in older adults – The Lancet Healthy Longevity, Volume 1, ISSUE 2, e55-e57, November 01, 2020



Job opportunities : Neurodegenerative disease modelling using scCRISPR screening

Three exciting job opportunities for two postdocs and one advanced research assistant to work on screening for genes involved in neurodegenerative disease using iPSC-derived cell types (neurons, astrocytes and microglia). This will use cutting edge CRISPR screening with a single cell RNAseq readout coupled with phenotypic assays to identify and characterise known and putative Alzheimer’s disease, Parkinson’s disease and ALS genes. Read more

£1m donation to support Longevity Science

A new gift of £1 million will support and advance the study of Longevity Science at Oxford and establish the Mellon Longevity Science Programme at Oriel to help the most vulnerable in society by advancing research into health resilience in ageing populations. Read more